NF-κB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted Therapy.

about

Canonical NF-KB pathway

P2860

Q66104598-E58F4748-E3A7-4480-8E1A-44B90D60F292

P2860

NF-κB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted Therapy.

Item

http://www.wikidata.org/entity/Q54247368

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

NF-κB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted Therapy.

@en

NF-κB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted Therapy.

@nl

type

Item

label

NF-κB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted Therapy.

@en

NF-κB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted Therapy.

@nl

prefLabel

NF-κB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted Therapy.

@en

NF-κB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted Therapy.

@nl

P1476

NF-κB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted Therapy.

@en

P2093

Anja Schmitt

http://www.w3.org/2001/XMLSchema#string

Klaus Schulze-Osthoff

http://www.w3.org/2001/XMLSchema#string

Paula Grondona

http://www.w3.org/2001/XMLSchema#string

Philip Bucher

http://www.w3.org/2001/XMLSchema#string

Stephan Hailfinger

http://www.w3.org/2001/XMLSchema#string

P2860

Atypical IκB proteins - nuclear modulators of NF-κB signaling

The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators

A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue

Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma

CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-kappa B

TAK1 is a ubiquitin-dependent kinase of MKK and IKK

Malt1 ubiquitination triggers NF-kappaB signaling upon T-cell activation

Phosphorylation of the CARMA1 linker controls NF-kappaB activation

De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling

Akirin2 is critical for inducing inflammatory genes by bridging IκB-ζ and the SWI/SNF complex

P31

scholarly article

P356

10.3390/BIOMEDICINES6020038

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29587428

http://www.w3.org/2001/XMLSchema#string

P921

NF-κB

P932

6027339

http://www.w3.org/2001/XMLSchema#string

NF-κB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted Therapy.

about

P2860

P2860

NF-κB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted Therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P577

P698

P921

P932